Reilly Charles C, Jolley Caroline J, Elston Caroline, Moxham John, Rafferty Gerrard F
King's College London, Faculty of Life Sciences and Medicine, London, UK; King's College Hospital, Physiotherapy, London, UK.
King's College London, Faculty of Life Sciences and Medicine, London, UK.
ERJ Open Res. 2016 Mar 5;2(1). doi: 10.1183/23120541.00057-2015. eCollection 2016 Jan.
The electromyogram recorded from the diaphragm (EMG) and parasternal intercostal muscle using surface electrodes (sEMG) provides a measure of neural respiratory drive (NRD), the magnitude of which reflects lung disease severity in stable cystic fibrosis. The aim of this study was to explore perception of NRD and breathlessness in both healthy individuals and patients with cystic fibrosis. Given chronic respiratory loading and increased NRD in cystic fibrosis, often in the absence of breathlessness at rest, we hypothesised that patients with cystic fibrosis would be able to tolerate higher levels of NRD for a given level of breathlessness compared to healthy individuals during exercise. 15 cystic fibrosis patients (mean forced expiratory volume in 1 s (FEV) 53.5% predicted) and 15 age-matched, healthy controls were studied. Spirometry was measured in all subjects and lung volumes measured in the cystic fibrosis patients. EMG and sEMG were recorded at rest and during incremental cycle exercise to exhaustion and expressed as a percentage of maximum (% max) obtained from maximum respiratory manoeuvres. Borg breathlessness scores were recorded at rest and during each minute of exercise. EMG % max and sEMG % max and associated Borg breathlessness scores differed significantly between healthy subjects and cystic fibrosis patients at rest and during exercise. The relationship between EMG % max and sEMG % max and Borg score was shifted to the right in the cystic fibrosis patients, such that at comparable levels of EMG % max and sEMG % max the cystic fibrosis patients reported significantly lower Borg breathlessness scores compared to the healthy individuals. At Borg score 1 (clinically significant increase in breathlessness from baseline) corresponding levels of EMG % max (20.2±12% 32.15±15%, p=0.02) and sEMG % max (18.9±8% 29.2±15%, p=0.04) were lower in the healthy individuals compared to the cystic fibrosis patients. In the cystic fibrosis patients EMG % max at Borg score 1 was related to the degree of airways obstruction (FEV) (r=-0.664, p=0.007) and hyperinflation (residual volume/total lung capacity) (r=0.710, p=0.03). This relationship was not observed for sEMG % max. These data suggest that compared to healthy individuals, patients with cystic fibrosis can tolerate much higher levels of NRD before increases in breathlessness from baseline become clinically significant. EMG % max and sEMG % max provide physiological tools with which to elucidate factors underlying inter-individual differences in breathlessness perception.
使用表面电极(sEMG)记录的膈肌肌电图(EMG)和胸骨旁肋间肌肌电图可提供神经呼吸驱动(NRD)的测量值,其大小反映了稳定期囊性纤维化患者的肺部疾病严重程度。本研究的目的是探讨健康个体和囊性纤维化患者对NRD的感知及呼吸困难情况。鉴于囊性纤维化患者存在慢性呼吸负荷增加和NRD升高,且常在静息时无呼吸困难,我们推测与健康个体相比,囊性纤维化患者在运动时对于给定程度的呼吸困难能够耐受更高水平的NRD。研究了15例囊性纤维化患者(1秒用力呼气容积(FEV)平均为预测值的53.5%)和15名年龄匹配的健康对照者。对所有受试者进行了肺功能测定,并对囊性纤维化患者测量了肺容积。在静息状态和递增式蹬车运动至力竭过程中记录EMG和sEMG,并表示为最大呼吸动作所获得最大值的百分比(% max)。在静息状态和运动的每分钟记录Borg呼吸困难评分。健康受试者与囊性纤维化患者在静息和运动时的EMG % max、sEMG % max及相关的Borg呼吸困难评分存在显著差异。囊性纤维化患者中,EMG % max和sEMG % max与Borg评分之间的关系向右偏移,即在EMG % max和sEMG % max水平相当的情况下,囊性纤维化患者报告的Borg呼吸困难评分显著低于健康个体。在Borg评分为1(呼吸困难较基线有临床意义的增加)时,健康个体的EMG % max相应水平(20.2±12%对32.15±15%,p = 0.02)和sEMG % max相应水平(18.9±8%对29.2±15%,p = 0.04)低于囊性纤维化患者。在囊性纤维化患者中,Borg评分为1时的EMG % max与气道阻塞程度(FEV)相关(r = -0.664,p = 0.007),与肺过度充气(残气量/肺总量)相关(r = 0.710,p = 0.03)。sEMG % max未观察到这种关系。这些数据表明,与健康个体相比,囊性纤维化患者在呼吸困难较基线增加至具有临床意义之前能够耐受更高水平的NRD。EMG % max和sEMG % max提供了生理工具,用以阐明个体间呼吸困难感知差异的潜在因素。